scholarly article | Q13442814 |
P356 | DOI | 10.1128/AAC.13.2.344 |
P953 | full work available at URL | https://europepmc.org/articles/PMC352239 |
https://europepmc.org/articles/PMC352239?pdf=render | ||
https://journals.asm.org/doi/pdf/10.1128/AAC.13.2.344 | ||
P932 | PMC publication ID | 352239 |
P698 | PubMed publication ID | 206203 |
P2093 | author name string | E. R. Kern | |
J. C. Overall | |||
L. A. Glasgow | |||
G. A. Olsen | |||
Overall JC Jr | |||
P2860 | cites work | Murine cytomegalovirus: induction of and sensitivity to interferon in vitro | Q34130034 |
Herpesvirus hominis Infection in Newborn Mice: Treatment with Interferon Inducer Polyinosinic-Polycytidylic Acid | Q34932464 | ||
Effect of Cytosine Arabinoside and 5-Iodo-2′-Deoxyuridine on a Cytomegalovirus Infection in Newborn Mice | Q34969754 | ||
Effect of Treatment with Exogenous Interferon, Polyinosinic Acid-Polycytidylic Acid, or Polyinosinic Acid-Polycytidylic Acid-Poly- l -Lysine Complex on Encephalomyocarditis Virus Infections in Mice | Q34981561 | ||
Susceptibility of Clinical Isolates of Cytomegalovirus to Human Interferon | Q36461814 | ||
Effect of interferon on systemic herpesvirus infections | Q39772793 | ||
Efficacy of Exogenous Interferon Treatment Initiated After Onset of Multiplication of Vesicular Stomatitis Virus in the Brains of Mice | Q39938168 | ||
Effect of Human Exogenous Leukocyte Interferon in Cytomegalovirus Infections | Q39996583 | ||
Effect of Leukocyte Interferon on Urinary Excretion of Cytomegalovirus by Infants | Q39996590 | ||
Effective Antiviral Chemotherapy in Cytomegalovirus Infection of Mice | Q39996614 | ||
Sensitivity of Types 1 and 2 Herpesvirus hominis to an Interferon Inducer, Poly I:C | Q40885758 | ||
Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine | Q44460660 | ||
Further studies on an inhibitor of viral activity appearing in infected cell cultures and its role in chronic viral infections | Q44937991 | ||
Interferon and cytomegalovirus in vivo and in vitro | Q47966069 | ||
Late Therapy with an Interferon Stimulator in an Arbovirus Encephalitis in Mice | Q71750460 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cytomegaloviral disease | Q2076966 |
pharmacology | Q128406 | ||
Cytomegalovirus | Q6946 | ||
P304 | page(s) | 344-346 | |
P577 | publication date | 1978-02-01 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complex | |
Treatment of a Murine Cytomegalovirus Infection with Exogenous Interferon, Polyinosinic-Polycytidylic Acid, and Polyinosinic-Polycytidylic Acid–Poly- l -Lysine Complex | |||
P478 | volume | 13 |
Q37056341 | Animal cytomegaloviruses |
Q42957459 | Cytomegalovirus induces interferon-stimulated gene expression and is attenuated by interferon in the developing brain. |
Q72938743 | Effect of acyclovir treatment on acute and chronic murine cytomegalovirus infection |
Q40599388 | Effects of immunosuppression with cyclophosphamide on acute murine cytomegalovirus infection and virus-augmented natural killer cell activity |
Q40101026 | Evaluation of interferon and interferon inducers as antiviral agents: Animal studies |
Q36328998 | Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. |
Q34022257 | Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything |
Q39509644 | Molecular biology and immunology of cytomegalovirus |
Q54237636 | Protection against murine cytomegalovirus infection in aged mice and mice with severe combined immunodeficiency disease with the biological response modifiers polyribosinic-polycytidylic acid stabilized with L-lysine and carboxymethylcellulose, male |
Q72727033 | Rat cytomegalovirus: induction of and sensitivity to interferon |
Q37827868 | Sources and signals regulating type I interferon production: lessons learned from cytomegalovirus |
Q72618750 | Susceptibility of Influenza Viruses to Interferon and to Poly (I) · Poly (C) Determined by the Plaque Reduction Method |
Q41984357 | Therapeutic effect of acyclovir (ZoviraxTM) on the pathogenesis of chronic murine cytomegalovirus infection in the immunodeficient nude mouse |
Search more.